Precigen shares rise 3.47% premarket after being added to S&P Biotechnology Select Industry Index.

Precigen, Inc. rose 3.47% in premarket trading, with the company being added to the S&P Biotechnology Select Industry Index. This inclusion is a positive development for the company, as it increases its visibility and potentially attracts more investors. Additionally, an insider sold shares worth $18,653,532, which could indicate a lack of confidence in the company's future prospects. However, the overall sentiment remains bullish due to the index inclusion.